Bankart + Remplissage Procedure: Participants will undergo arthroscopic stabilization.
Latarjet Procedure: Participants will undergo open or arthroscopic Latarjet procedure.
Study summary
The primary objective of the study is to evaluate the functional shoulder recovery of patients with recurrent shoulder dislocations at 24 months when treated with either arthroscopic capsuloligamentous repair (Bankart Procedure +/- Remplissage) or coracoid transfer (Latarjet procedure).
Eligibility
Sex
ALL
Min age
18 Years
Max age
50 Years
Healthy volunteers
No
Inclusion Criteria:
1. Adults ages 18-50 years;
2. Diagnosis of post-traumatic recurrent anterior dislocation. This will require a minimum of 2 episodes of documented dislocations either by radiographic evidence or documented reduction of anterior shoulder dislocation as well as physical examination eliciting unwanted glenohumeral translation with reproduction of symptoms;
3. Subcritical glenoid bone loss as defined on CT by standardized and reproducible best-fit circle technique (\>10% but \<20%);
4. Provision of informed consent.
Exclusion Criteria:
1. Patients with concomitant injuries of the index shoulder (cuff tear, greater tuberosity fracture);
2. Previous shoulder surgery;
3. Patients that will likely have problems, in the judgment of the investigators, with maintaining follow-up;
4. Epilepsy/seizure disorder;
5. Patients who are currently incarcerated;
6. Diagnosis of multidirectional instability;
7. Cases involving litigation or workplace insurance claims (e.g. WSIB);
8. Confirmed connective tissue disorder (Ehlers-Danlos, Marfans) or Beighton hypermobility score \> 6.
9. Pregnancy.
Primary outcome measure(s)
Clinical Outcome - Shoulder function — 2 years The change from baseline to 24 months post-intervention difference in Western Ontario Shoulder Instability Index (WOSI) scores between patients with recurrent dislocations treated with Bankart Procedure + Remplissage versus Latarjet procedure.
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
We use cookies to analyse site traffic and improve your experience. With your consent, we may also use cookies for advertising. You can change your choice at any time.